期 |
栏目 |
标题 |
文件 |
卷 22, 编号 1 (2020) |
CLINICAL ONCOLOGY |
Solitary (extramedullary) plasmocytoma. Clinical recommendations |
(Rus)
|
卷 22, 编号 2 (2020) |
Guidelines |
Hodgkin's lymphoma |
(Rus)
|
卷 22, 编号 2 (2020) |
Guidelines |
Follicular lymphoma |
(Rus)
|
卷 22, 编号 2 (2020) |
Review |
Biobanks in oncology: global experience and Russian reality |
(Rus)
|
卷 22, 编号 4 (2020) |
CLINICAL ONCOLOGY |
Multiple myeloma |
(Rus)
|
卷 22, 编号 4 (2020) |
CLINICAL ONCOLOGY |
Differentiated thyroid cancer |
(Rus)
|
卷 23, 编号 1 (2021) |
CLINICAL ONCOLOGY |
Modern approaches in the first line treatment of CD30-positive peripheral T-cell lymphomas |
(Rus)
|
卷 23, 编号 2 (2021) |
CLINICAL ONCOLOGY |
Prostate cancer |
(Rus)
|
卷 23, 编号 3 (2021) |
CLINICAL ONCOLOGY |
Malignant neoplasms associated with HIV infection. Problems and solutions (problem outline) |
(Rus)
|
卷 23, 编号 4 (2021) |
CLINICAL ONCOLOGY |
Malignant neoplasms in HIV patients in Russia: the story over a 20-year period |
(Rus)
|
卷 23, 编号 4 (2021) |
CLINICAL ONCOLOGY |
Gastric cancer: Russian clinical guidelines |
(Rus)
|
卷 26, 编号 2 (2024) |
Articles |
Safety of Pembroria® during non-medical switching from Keytruda® in patients with advanced malignant neoplasms of various localizations: the REFLECTION real-world study |
(Rus)
|